Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Covid 19 Infection on Fetomaternal Outcome

NCT05160649

COVID-19 COVID-19 Pneumonia Fetal Growth Retardation

UNKNOWN

Effect of Covid-19 on Outcomes of Pregnancy

NCT04629001

Pregnancy Without Complications Except Getting Covid-19 Infection

UNKNOWN

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy

NCT04319016

Infection Viral

UNKNOWN

The Impact of COVID-19 on Maternal and Neonatal Outcomes

NCT05197621

COVID-19 Pregnancy; Infection

RECRUITING

Impact of COVID-19 Infection During Pregnancy

NCT05139953

Covid-19 in Pregnancy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this cross sectional study,the following questions require immediate attention: whether COVID-19 symptoms in pregnant women differ from symptoms in non-pregnant women; whether disease complications and mortality rates are higher in pregnant women than in non-pregnant women; and whether there is a risk of premature delivery, foetal mortality, or even vertical transmission of the disease. These questions must be answered in order to plan optimal obstetrical management for pregnant women with COVID-19

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Pandemic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women of any gestational age with confirmed COVID 19 diagnosis attended and admitted at inpatient ward for management and follow up from April 2020 to December 2021at Kasr El Ainy hospital,Cairo university

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No